Shilpa Medicare gets GMP certificate from MOH-Russia for API facility in Karnataka

18 Jul 2022 Evaluate

Shilpa Medicare has received GMP certificate from MOH-Russia for its API facility (unit-1) located at Raichur, Karnataka. The facility was audited by the agency on February 17, 2022, February 18, 2022 and February 21, 2022. The facility involves in manufacturing, testing, packing, storage of chemically synthesized nonsterile drug substances for human use.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

323.70 9.05 (2.88%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×